Neuphoria Therapeutics In...

NASDAQ: NEUP · Real-Time Price · USD
8.15
0.05 (0.62%)
At close: Aug 15, 2025, 3:43 PM

Neuphoria Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
PE Ratio
-80.06 -226.79 -631.99 -2.34K
PEG Ratio
1.94 -7.37 -21.07 257.78
PS Ratio
n/a n/a 1.56K 16.5K
PB Ratio
70.92 220.31 241.63 428.20
P/FCF Ratio
-84.49 -331.27 -632.06 -2.7K
P/OCF Ratio
-84.49 -331.27 -632.1 -2.7K
OCF/S Ratio
n/a n/a -2.47 -6.1
Debt / Equity Ratio
0.02 0.02 0.01 0.02
Quick Ratio
3.45 4.87 12.46 13.10
Current Ratio
3.45 4.87 12.46 13.10
Asset Turnover
n/a n/a 0.13 0.02
Interest Coverage
n/a -1.53K -794.21 -8.32
Return on Equity
-0.89 -0.97 -0.38 -0.18
Return on Assets
-0.56 -0.75 -0.33 -0.16
Return on Invested Capital
-0.74 -0.83 -0.34 -0.22
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a -1.64 -5.21
Net Profit Margin
n/a n/a -2.47 -7.04
Pretax Profit Margin
n/a n/a -2.49 -7.19
Operating Profit Margin
n/a n/a -2.42 -9.65
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -2.36 -4.86